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Abstract 
Medicinal plants are globally valuable sources of herbal products, and they are disappearing at a high speed. This 
article reviews global trends, developments and prospects for the strategies and methodologies concerning the 
conservation and sustainable use of medicinal plant resources to provide a reliable reference for the conservation and 
sustainable use of medicinal plants. We emphasized that both conservation strategies (e.g. in situ and ex situ con‑
servation and cultivation practices) and resource management (e.g. good agricultural practices and sustainable use 
solutions) should be adequately taken into account for the sustainable use of medicinal plant resources. We recom‑
mend that biotechnical approaches (e.g. tissue culture, micropropagation, synthetic seed technology, and molecular 
marker‑based approaches) should be applied to improve yield and modify the potency of medicinal plants.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Medicinal plants are globally valuable sources of new 
drugs [1–4]. There are over 1300 medicinal plants used in 
Europe, of which 90 % are harvested from wild resources; 
in the United States, about 118 of the top 150 prescrip-
tion drugs are based on natural sources [5]. Furthermore, 
up to 80 % of people in developing countries are totally 
dependent on herbal drugs for their primary healthcare, 
and over 25  % of prescribed medicines in developed 
countries are derived from wild plant species [4]. With 
the increasing demand for herbal drugs, natural health 
products, and secondary metabolites of medicinal plants, 
the use of medicinal plants is growing rapidly throughout 
the world [1, 6].
A highly conservative estimate states that the cur-
rent loss of plant species is between 100 and 1000 times 
higher than the expected natural extinction rate and 
that the Earth is losing at least one potential major drug 
every 2  years [7]. According to the International Union 
for Conservation of Nature and the World Wildlife Fund, 
there are between 50,000 and 80,000 flowering plant 
species used for medicinal purposes worldwide. Among 
these, about 15,000 species are threatened with extinc-
tion from overharvesting and habitat destruction [8] and 
20  % of their wild resources have already been nearly 
exhausted with the increasing human population and 
plant consumption [9]. Although this threat has been 
known for decades, the accelerated loss of species and 
habitat destruction worldwide has increased the risk of 
extinction of medicinal plants, especially in China [1, 10], 
India [10, 11], Kenya [11], Nepal [11], Tanzania [12] and 
Uganda [12].
The conservation and sustainable use of medicinal 
plants have been studied extensively [13, 14]. Various sets 
of recommendations have been compiled regarding their 
conservation, including the establishment of systems for 
species inventorying and status monitoring, and the need 
for coordinated conservation practices based on both 
in  situ and ex situ strategies [4]. For medicinal plants 
with increasingly limited supplies, sustainable use of wild 
resources can be an effective conservation alternative. In 
China and South Africa, the situation is particularly criti-
cal because of the high demands of large populations.
This article reviews global trends, developments and 
prospects of the strategies and methodologies concerning 
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We conducted systematic literature searches in the ISI 
Web of Science, PubMed and CNKI databases using 
search terms (e.g. “medicinal plant”, “herbal drug”, “herbal 
medicine”, “aromatic plant”, and “Chinese medicine”) 
and keyword combinations (e.g. “in situ conservation”, 
“ex situ conservation”, “sustainable use”, and “cultivation 
practice”) to retrieve the abstracts of relevant articles 
(Fig.  1). The literature search spanned the period from 
January 2000 to December 2014, and the languages were 
limited to English and Chinese. We carefully reviewed 
all retrieved abstracts to find articles that were suitable 
according to the inclusion criteria (Table  1). For litera-
ture focusing on the conservation and/or sustainable use 
of medicinal plants, we retrieved full articles from full-
text databases (ScienceDirect, Wiley, Biomed, Springer, 
Medline, Scopus, Elsevier, Highwire, Mcgill, Cogprints, 
Emedicine, Nature and Science online). From the initial 
search, a total of 673 abstracts were collected, including 
research articles, reviews, commentaries and letters. 
After systematic screening, 231 met the inclusion crite-
ria. From these, full copies of 106 articles were retrieved 
for further evaluation. In addition, we retrieved 25 non-
indexed but relevant citations from the reference lists of 
retrieved articles to supplement the above searches and 
provide a complete literature retrieval.
Diversity of medicinal plants used worldwide
More than one-tenth of plant species are used in drugs 
and health products, with more than 50,000 species 
being used. However, the distribution of medicinal plants 
is not uniform across the world [15, 16]. For example, 
China and India have the highest numbers of medicinal 
plants used, with 11,146 and 7500 species, respectively, 
followed by Colombia, South Africa, the United States, 
and another 16 countries with percentages of medicinal 
plants ranging from 7 % in Malaysia to 44 % in India ver-
sus their total numbers of plant species [16–19] (Fig. 2). 
Certain plant families not only have higher numbers of 
medicinal plants, but also have higher proportions of 
threatened species than others [15]. Only a portion of 
medicinal plants that suffer from genetic erosion and 
resource destruction have been listed as threatened [20, 
21].
Factors related to species rarity of medicinal plants
Species rarity is used to assess the extinction risk of 
medicinal plants, and to identify those species most at 
risk of extinction, prior to commencement of conserva-
tion efforts [22]. It is necessary to determine how rare 
each species is and in which ways rare species differ from 
one another. Not all medicinal plants are affected in the 
same way by harvesting pressures [23, 24]. Overexploita-
tion, indiscriminate collection, uncontrolled deforesta-
tion, and habitat destruction all affect species rarity, but 
are insufficient to explain individual species susceptibil-
ity or resilience to harvest pressure. Multiple biological 
characters correlate with extinction risk, such as habitat 
specificity, distribution range, population size, species 
diversity, growth rate, and reproductive system (Table 2; 
Fig. 3).
Conservation strategies
Medicinal plant resources are being harvested in increas-
ing volumes, largely from wild populations. Indeed, 
demand for wild resources has increased by 8–15 % per 
year in Europe, North America, and Asia in recent dec-
ades [8, 9]. There is a threshold below which species 
reproductive capacity becomes irreversibly reduced [25, 
26]. Various sets of recommendations relating to the 
conservation of medicinal plants have been developed, 
such as providing both in  situ and ex situ conservation 
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PUBMED (n2=185) 
and CNKI (n3=126) 








(Bsased on inclusion criteria)
(n=231)
Full papers retrieved 
(n=106)
Database sources:
ScienceDirect, Wiley, Mcgill, 
Medline, Scopus, Elsevier, 
Biomed, Springer, Highwire, 















Fig. 1 Diagram for literature selection
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(Table 2) [15, 27]. Natural reserves and wild nurseries are 
typical examples to retain the medical efficacy of plants 
in their natural habitats, while botanic gardens and seed 
banks are important paradigms for ex situ conservation 
and future replanting [28, 29] (Fig.  4). The geographic 
distribution and biological characteristics of medicinal 
plants must be known to guide conservation activities, 
e.g. to assess whether species conservation should take 
place in nature or in a nursery.
In situ conservation
Most medicinal plants are endemic species, and their 
medicinal properties are mainly because of the pres-
ence of secondary metabolites that respond to stimuli 
in natural environments, and that may not be expressed 
under culture conditions [22, 29]. In  situ conservation 
of whole communities allows us to protect indigenous 
plants and maintain natural communities, along with 
their intricate network of relationships [30]. Addition-
ally, in  situ conservation increases the amount of diver-
sity that can be conserved [31], and strengthens the link 
between resource conservation and sustainable use [32]. 
In  situ conservation efforts worldwide have focused on 
establishing protected areas and taking an approach that 
is ecosystem-oriented, rather than species-oriented [33]. 
Successful in  situ conservation depends on rules, regu-
lations, and potential compliance of medicinal plants 
within growth habitats [25, 34].
Natural reserves The degradation and destruction of 
habitats is a major cause of the loss of medicinal plant 
resources [35]. Natural reserves are protected areas of 
Table 1 The inclusion and exclusion criteria for study selection
Subjects Criteria description
Inclusion criteria The subject is about medicinal plants
The purpose is to conserve or sustainably use
It has a detailed description of the strategy of conservation, sustainable use or resource management
Consistent to the three items simultaneously
Exclusion criteria The subject is not related to medicinal plants (e.g. animals or mineral substances)
The purpose is not for conservation or sustainable use of medicinal plants (e.g. herb extraction, drug discovery, chemical constituent 
or pharmacological property)



































































































































Fig. 2 Number and percentage of medicinal plant species in different countries. The light bars indicate the number of medicinal plant species, and 
the dark dots indicate the percentage of medicinal plants compared with the total number of plant species. Data sources from Rafieian‑Kopaei [16], 
Hamilton [17], Marcy et al. [18], and Srujana et al. [19]
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important wild resources created to preserve and restore 
biodiversity [36, 37]. Around the world, more than 12,700 
protected areas have been established, accounting for 
13.2 million km2, or 8.81 % of the Earth’s land surface [38]. 
Conserving medicinal plants by protecting key natural 
habitats requires assessing the contributions and ecosys-
tem functions of individual habitats [39].
Wild nurseries It is impossible to designate every natu-
ral wild plant habitat as a protected area, owing to cost 
considerations and competing land uses [25, 40]. A wild 
nursery is established for species-oriented cultivating and 
domesticating of endangered medicinal plants in a pro-
tected area, natural habitat, or a place that is only a short 
distance from where the plants naturally grow [4, 20, 41]. 
Although the populations of many wild species are under 
heavy pressure because of overexploitation, habitat deg-
radation and invasive species, wild nurseries can provide 
an effective approach for in situ conservation of medicinal 
plants that are endemic, endangered, and in-demand [27, 
42].
Ex situ conservation
Ex situ conservation is not always sharply separated from 
in  situ conservation, but it is an effective complement 
to it, especially for those overexploited and endangered 
medicinal plants with slow growth, low abundance, and 
high susceptibility to replanting diseases [4, 43, 44]. Ex 
situ conservation aims to cultivate and naturalize threat-
ened species to ensure their continued survival and 
sometimes to produce large quantities of planting mate-
rial used in the creation of drugs, and it is often an imme-
diate action taken to sustain medicinal plant resources 
[45, 46]. Many species of previously wild medicinal plants 
can not only retain high potency when grown in gardens 
far away from the habitats where they naturally occur, but 
can have their reproductive materials selected and stored 
in seed banks for future replanting [4].
Botanic gardens Botanic gardens play an important role 
in ex situ conservation [43], and they can maintain the 
ecosystems to enhance the survival of rare and endan-
gered plant species [38]. Although living collections gen-
erally consist of only a few individuals of each species 
and so are of limited use in terms of genetic conservation 
[47], botanic gardens have multiple unique features. They 
involve a wide variety of plant species grown together 
under common conditions, and often contain taxonomi-
cally and ecologically diverse flora [48]. Botanic gardens 
can play a further role in medicinal plant conservation 
through the development of propagation and cultivation 
protocols, as well as undertaking programs of domestica-























Fig. 3 Factors contributing to the susceptibility or resilience of 
medicinal plants in response to collection pressure. Factors include 
distribution range, habitat specificity, population size, species diver‑
sity, growth rate, and reproductive system. The dark line indicates less 
susceptible characteristics of medicinal plants, while the dashed line 













Fig. 4 Diagram of methodological systems involved in the conserva‑
tion of medicinal plants
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Seed banks Seed banks offer a better way of storing the 
genetic diversity of many medicinal plants ex situ than 
through botanic gardens, and are recommended to help 
preserve the biological and genetic diversity of wild plant 
species [50, 51]. The most noteworthy seed bank is the 
Millennium Seed Bank Project at the Royal Botanic Gar-
dens in Britain [51]. Seed banks allow relatively rapid 
access to plant samples for the evaluation of their prop-
erties, providing helpful information for conserving the 
remaining natural populations [50, 51]. The challenging 
tasks of seed banking are how to reintroduce the plant 
species back into the wild and how to actively assist in the 
restoration of wild populations [50].
Cultivation practice
Although wild-harvested resources of medicinal plants 
are widely considered more efficacious than those that 
are cultivated, domestic cultivation is a widely used and 
generally accepted practice [30, 52, 53]. Cultivation pro-
vides the opportunity to use new techniques to solve 
problems encountered in the production of medicinal 
plants, such as toxic components, pesticide contamina-
tion, low contents of active ingredients, and the misi-
dentification of botanical origin [54]. Cultivation under 
controlled growth conditions can improve the yields 
of active compounds, which are almost invariably sec-
ondary metabolites, and ensures production stability 
(Table  3). Cultivation practices are designed to provide 
optimal levels of water, nutrients, optional additives, and 
environmental factors including temperature, light and 
humidity to obtain improved yields of target products 
[27, 55]. Moreover, increased cultivation contributes to 
decreases in the harvest volume of medicinal plants, ben-
efits the recovery of their wild resources, and decreases 
their prices to a more reasonable range [4, 13, 20] (Fig. 5).
Good agricultural practices (GAP)
Good agricultural practices (GAP) for medicinal plants 
have been formulated to regulate production, ensure 
quality, and facilitate the standardization of herbal drugs 
[56]. A GAP approach ensures high quality, safe and 
pollution-free herbal drugs (or crude drugs) by applying 
available knowledge to address various problems [57]. 
GAP include comprehensive items, such as the ecological 
environment of production sites, germplasm, cultivation, 
collection, and quality aspects of pesticide detection, 
macroscopic or microscopic authentication, chemical 
identification of bioactive compounds, and inspection 
of metal elements [58]. Many countries actively pro-
mote the implementation of GAP. For example, Chinese 
authorities have promoted GAP for the growth of com-
monly used herbal drugs in regions where those medici-
nal plants are traditionally cultivated [27, 33].
Organic farming has received increasing attention for 
its ability to create integrated, humane, and environmen-
tally and economically sustainable production systems 
Table 3 The advantages and disadvantages of wild resource versus cultivated medicinal plant species
Information from Hamilton [4], Schippmann et al. [20], Liu et al. [27], and Raina et al. [54]
Characteristics Wild resource Cultivated species
Advantages It is open access resource without investment It relieves harvesting pressure on rare and threatened species
It is natural resource and free from pesticides It can keep genotypes being standardized or improved
Wild resource is supposed to be more efficacious It guarantees continuing supply of raw medicinal materials
Production volume and price can be stable for longer periods
Disadvantages Wild resource is becoming scarce and threatened by over‑
harvesting
It needs substantial investment before and during production
There exists a risk of adulterations and resource exhaustion It narrows genetic diversity in gene pool of wild populations
Uncontrolled harvesting leads to the extinction of ecotype and 
species
Reintroduced plants can cause genetic pollution of wild resource
There is a lack of resource inventories and related management 
practices
Cultivated species may have negative impacts on ecosystems
There is a lack of successful cultivation techniques for some spe‑
cies
Page 7 of 10Chen et al. Chin Med  (2016) 11:37 
for medicinal plants, [59, 60]. The aims of organic farm-
ing of medicinal plants include producing material with 
better quality and high productivity, and ensuring the 
conservation and sustainable utilization of those plants 
(Table  4). The defining characteristic of organic farm-
ing is the non-use of synthetic fertilizers, pesticides and 
herbicides, which are not allowed according to many 
current organic certification standards in Europe and 
North America [59]. Organic farming is benign to the 
environment, and relies upon farm-derived renewable 
resources to maintain biological processes of medici-
nal plants and ecological balance of habitates [56, 59]. 
The use of organic fertilizers continuously supplies soil 
nutrients and improves soil stability, significantly affect-
ing the growth of medicinal plants and the biosynthesis 
of essential substances. For example, when organic ferti-
lizers were applied, the biomass yield of Chrysanthemum 
balsamita was increased and its essential oil content was 
high relative to those free from organic fertilizers [61]. 
Organic farming of medicinal plants is becoming increas-
ingly important in the long-term development and sus-
tainability of medicinal plants [60].
Sustainable use
For medicinal plants with limited abundance and slow 
growth, destructive harvesting generally results in 
resource exhaustion and even species extinction [13, 62]. 
Therefore, the sustainable use of medicinal plants should 
be considered, and good harvesting practices must be 
formulated. Root and whole-plant harvesting is more 
destructive to medicinal plants (e.g. herbs, shrubs and 
trees) than collecting their leaves and flowers or buds 
(Table 5). For herbal drugs made of whole plants or roots, 
using their leaves as a remedy can be a benign alternative. 
For example, Wang et  al. [63] discovered that extracts 
from ginseng leaf-stems and roots have similar pharma-
cological activities, but ginseng leaf-stem has the advan-
tage of being a more sustainable resource.
Prospects
The development of genetic engineering has led to the 
feasibility of large-scale biosynthesis of natural products, 
and advancements in tissue culture and fermentation of 
medicinal plants have opened new avenues for the large-
scale and highly efficient production of desirable bioac-
tive compounds. Tissue culture (including plant cell and 
transgenic hairy root culture) is a promising alternative 
for the production of rare and high-value secondary 
metabolites of medical importance [64]. Micropropaga-
tion via tissue encapsulation of propagules can not only 
facilitate storage and transportation, but also promotes 
higher regeneration rates [62]. When the amounts of 
normal seeds are insufficient for propagation, synthetic 
seed technology, defined as artificially encapsulated 
somatic embryos (or other tissues) could be used for cul-
tivate in vitro or ex vitro, is a feasible alternative [65, 66]. 
Furthermore, breeding improvements can be carried out 
using molecular marker-based approaches applied at the 
genetic level, and the time required for breeding may be 










Discovery Stabilization Decline Extinction
Discovery Stabilization Decline Recovery
Fig. 5 Price and harvest volume variation in the transition from 
wild‑harvesting to cultivation of medicinal plants. As wild resources 
decline with overharvesting, the price of raw material increases 
accordingly. Therefore, cultivation becomes economically feasible for 
price stabilization and resource recovery of medicinal plants. Data 
sources from Hamilton [4], Larsen and Olsen [13], Schippmann et al. 
[20], Chan et al. [56], and Schippmann et al. [67]
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Conclusion
Despite the existence of various sets of recommendations 
for the conservation and sustainable use of medicinal 
plants, only a small portion of these have achieved ade-
quate protection of medicinal plant resources through 
conventional conservation in natural reserves or botanic 
gardens.
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